Literature DB >> 21051253

Pathology of the first autopsy case diagnosed as mucolipidosis type III α/β suggesting autophagic dysfunction.

Hiroshi Kobayashi1, Junko Takahashi-Fujigasaki, Takahiro Fukuda, Ken Sakurai, Yohta Shimada, Koichi Nomura, Masamichi Ariga, Toya Ohashi, Yoshikatsu Eto, Takanobu Otomo, Norio Sakai, Hiroyuki Ida.   

Abstract

Mucolipidosis type III (MLIII) is a mild form of Mucolipidosis type II (MLII, I-cell disease) of late onset, of which almost no pathological study has been reported, as it is a very rare disease. We encountered the case of a 23-year-old man of Japanese and Caucasian mixed parentage diagnosed with MLIII by enzyme assay and genotyping. He died suddenly due to severe dilated cardiomyopathy. On the day after his death, autopsy was performed, and accumulation of Luxol Fast Blue (LFB) positive material was found to be most severe in the neuronal cells of dorsal root ganglions (DRG). Electromicroscopic DRG revealed the neuronal cytoplasm was filled with a zebra-body-like membranous matrix. We tried immunohistochemistry to investigate the mechanism of such accumulation in the DRG that resulted in double positive anti-ubiquitin antibody (FK-2) and anti-LC3 antibody (as specific marker for autophagy) staining, and speculated activating of autophagosome pathway, and 'zebra-body' should be suspected as dysfunctional autophagosome. We also detected foamy cell proliferation in the dura mater, Auerbach's plexus (peripheral nervous system), podocytes of almost all glomeruli, cartilage tissue in lumbar discs, and in cardiac muscle. We tried FK-2 and anti-LC3 antibody staining also for the podocytes, the area with the most marked proliferation of foamy cells, but the result was negative. This led us to speculate that these pathological findings, namely, accumulation of LFB-positive material and foamy fibroblast proliferation, might be the forms of dysfunctional autophagosome at various stages of development. This pathological study of MLIII supports the theory that MLIII is a mild type of MLII because of the close similarity of their pathological findings.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21051253     DOI: 10.1016/j.ymgme.2010.09.014

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  9 in total

1.  Distinct Modes of Balancing Glomerular Cell Proteostasis in Mucolipidosis Type II and III Prevent Proteinuria.

Authors:  Wiebke Sachs; Marlies Sachs; Elke Krüger; Stephanie Zielinski; Oliver Kretz; Tobias B Huber; Anke Baranowsky; Lena Marie Westermann; Renata Voltolini Velho; Nataniel Floriano Ludwig; Timur Alexander Yorgan; Giorgia Di Lorenzo; Katrin Kollmann; Thomas Braulke; Ida Vanessa Schwartz; Thorsten Schinke; Tatyana Danyukova; Sandra Pohl; Catherine Meyer-Schwesinger
Journal:  J Am Soc Nephrol       Date:  2020-07-08       Impact factor: 10.121

2.  Lysosomal storage causes cellular dysfunction in mucolipidosis II skin fibroblasts.

Authors:  Takanobu Otomo; Katsumi Higaki; Eiji Nanba; Keiichi Ozono; Norio Sakai
Journal:  J Biol Chem       Date:  2011-08-16       Impact factor: 5.157

Review 3.  Emerging role of autophagy in kidney function, diseases and aging.

Authors:  Tobias B Huber; Charles L Edelstein; Björn Hartleben; Ken Inoki; Man Jiang; Daisuke Koya; Shinji Kume; Wilfred Lieberthal; Nicolas Pallet; Alejandro Quiroga; Kameswaran Ravichandran; Katalin Susztak; Sei Yoshida; Zheng Dong
Journal:  Autophagy       Date:  2012-06-13       Impact factor: 16.016

Review 4.  Autophagy in lysosomal storage disorders.

Authors:  Andrew P Lieberman; Rosa Puertollano; Nina Raben; Susan Slaugenhaupt; Steven U Walkley; Andrea Ballabio
Journal:  Autophagy       Date:  2012-05-01       Impact factor: 16.016

5.  Hematopoietic Disorders, Renal Impairment and Growth in Mucopolysaccharidosis-Plus Syndrome.

Authors:  Viktoriia Sofronova; Rina Iwata; Takuya Moriya; Kiunniai Loskutova; Elizaveta Gurinova; Mairanush Chernova; Anastasia Timofeeva; Anna Shvedova; Filipp Vasilev; Saina Novgorodova; Seigo Terawaki; Takahito Moriwaki; Aitalina Sukhomyasova; Nadezhda Maksimova; Takanobu Otomo
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

6.  A novel intermediate mucolipidosis II/IIIαβ caused by GNPTAB mutation in the cytosolic N-terminal domain.

Authors:  Jules G Leroy; David Sillence; Tim Wood; Jarrod Barnes; Robert Roger Lebel; Michael J Friez; Roger E Stevenson; Richard Steet; Sara S Cathey
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

Review 7.  Lysosomal Storage Diseases-Regulating Neurodegeneration.

Authors:  Rob U Onyenwoke; Jay E Brenman
Journal:  J Exp Neurosci       Date:  2016-04-05

8.  Mucolipidosis type III, a series of adult patients.

Authors:  Esmee Oussoren; David van Eerd; Elaine Murphy; Robin Lachmann; Jan C van der Meijden; Lies H Hoefsloot; Rob Verdijk; George J G Ruijter; Mario Maas; Carla E M Hollak; Janneke G Langendonk; Ans T van der Ploeg; Mirjam Langeveld
Journal:  J Inherit Metab Dis       Date:  2018-04-27       Impact factor: 4.982

Review 9.  Lysosome function in glomerular health and disease.

Authors:  Catherine Meyer-Schwesinger
Journal:  Cell Tissue Res       Date:  2021-01-12       Impact factor: 4.051

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.